Raquel Abecasis

1.5k total citations
19 papers, 628 citations indexed

About

Raquel Abecasis is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Raquel Abecasis has authored 19 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 13 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Raquel Abecasis's work include Liver Disease and Transplantation (17 papers), Liver Disease Diagnosis and Treatment (13 papers) and Pancreatitis Pathology and Treatment (3 papers). Raquel Abecasis is often cited by papers focused on Liver Disease and Transplantation (17 papers), Liver Disease Diagnosis and Treatment (13 papers) and Pancreatitis Pathology and Treatment (3 papers). Raquel Abecasis collaborates with scholars based in Argentina and Cuba. Raquel Abecasis's co-authors include Rubén Terg, Diana Levi, E Fassio, Gustavo Adolfo Sierra Romero, Adrián Gadano, Graciela Landeira, Mónica Guevara, Mariano Cartier, Carlos Míguez and Alberto Muñoz and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

Raquel Abecasis

19 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raquel Abecasis Argentina 11 495 479 244 55 54 19 628
Miquel Torres Spain 4 540 1.1× 592 1.2× 250 1.0× 63 1.1× 24 0.4× 5 788
Mariano Cartier Argentina 9 365 0.7× 325 0.7× 151 0.6× 32 0.6× 46 0.9× 13 446
Paz Valer Spain 4 383 0.8× 329 0.7× 213 0.9× 97 1.8× 38 0.7× 7 517
K C Tan United Kingdom 17 761 1.5× 514 1.1× 565 2.3× 14 0.3× 71 1.3× 34 1.2k
R.D. Abeles United Kingdom 10 450 0.9× 439 0.9× 183 0.8× 20 0.4× 82 1.5× 17 567
Esther Buzaglo Dantas-Corrêa Brazil 11 324 0.7× 336 0.7× 89 0.4× 23 0.4× 42 0.8× 30 434
W. Debernardi‐Venon Italy 10 756 1.5× 664 1.4× 320 1.3× 67 1.2× 45 0.8× 19 844
Giuseppe Cullaro United States 15 566 1.1× 477 1.0× 279 1.1× 89 1.6× 49 0.9× 52 843
Franco Bissoli Italy 10 481 1.0× 438 0.9× 135 0.6× 20 0.4× 122 2.3× 18 661
L. Martín‐Herrera Spain 9 427 0.9× 378 0.8× 144 0.6× 35 0.6× 28 0.5× 11 573

Countries citing papers authored by Raquel Abecasis

Since Specialization
Citations

This map shows the geographic impact of Raquel Abecasis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raquel Abecasis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raquel Abecasis more than expected).

Fields of papers citing papers by Raquel Abecasis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raquel Abecasis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raquel Abecasis. The network helps show where Raquel Abecasis may publish in the future.

Co-authorship network of co-authors of Raquel Abecasis

This figure shows the co-authorship network connecting the top 25 collaborators of Raquel Abecasis. A scholar is included among the top collaborators of Raquel Abecasis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raquel Abecasis. Raquel Abecasis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Inzaugarat, María Eugenia, et al.. (2011). Altered Phenotype and Functionality of Circulating Immune Cells Characterize Adult Patients with Nonalcoholic Steatohepatitis. Journal of Clinical Immunology. 31(6). 1120–1130. 95 indexed citations
2.
Cartier, Mariano, Rubén Terg, Alberto Muñoz, et al.. (2010). Pilot study: Gelafundin (polygeline) 4% plus antibiotics in the treatment of high‐risk cirrhotic patients with spontaneous bacterial peritonitis. Alimentary Pharmacology & Therapeutics. 32(1). 43–48. 9 indexed citations
3.
Hwang, Hui Jer, Edgardo Smecuol, Horacio Vázquez, et al.. (2010). M1267 Increased Intestinal Permeability (IP) in Cirrhosis is Associated to the Severity of the Liver Disease and a Higher Mortality. Gastroenterology. 138(5). S–367. 2 indexed citations
4.
Terg, Rubén, Adrián Gadano, Mariano Cartier, et al.. (2009). Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study. Liver International. 29(3). 415–419. 92 indexed citations
5.
Terg, Rubén, E Fassio, Mónica Guevara, et al.. (2008). Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: A randomized, placebo-controlled study. Journal of Hepatology. 48(5). 774–779. 96 indexed citations
6.
Terg, Rubén, Alicia M. Sambuelli, Mariano Cartier, et al.. (2008). Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.. PubMed. 38(1). 26–33. 29 indexed citations
7.
Guevara, Mónica, Raquel Abecasis, & Rubén Terg. (2004). Effect of celecoxib on renal function in cirrhotic patients with ascites. A pilot study. Scandinavian Journal of Gastroenterology. 39(4). 385–386. 16 indexed citations
8.
Abecasis, Raquel, David Kravetz, E Fassio, et al.. (2003). Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study. Hepatology. 37(2). 359–365. 41 indexed citations
9.
Abecasis, Raquel, et al.. (2002). Effect of celecoxib on renal function in cirrhotic patients with ascites. A pilot study. Journal of Hepatology. 36. 203–203. 5 indexed citations
10.
Abecasis, Raquel, et al.. (2001). Long-term Efficacy of Torsemide Compared with Frusemide in Cirrhotic Patients with Ascites. Scandinavian Journal of Gastroenterology. 36(3). 309–313. 9 indexed citations
11.
12.
13.
Terg, Rubén, E Fassio, Graciela Landeira, et al.. (2000). Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study. Journal of Hepatology. 33(4). 564–569. 64 indexed citations
14.
Heras, M. De las, Raquel Abecasis, Rubén Terg, et al.. (1997). Daily Variation in Portal Blood Flow and the Effect of Propranolol Administration in A Randomized Study of Patients With Cirrhosis. Hepatology. 25(3). 548–550. 20 indexed citations
15.
Levi, Diana, Eduardo Mauriño, Raquel Abecasis, et al.. (1996). Splenic hypofunction in cirrhosis is not associated with increased risk for infections. European Journal of Gastroenterology & Hepatology. 8(3). 257–260. 7 indexed citations
16.
Terg, Rubén, Diana Levi, Sergio Rojter, et al.. (1992). Analysis of clinical course and prognosis of culture-positive spontaneous bacterial peritonitis and neutrocytic ascites. Digestive Diseases and Sciences. 37(10). 1499–1504. 39 indexed citations
17.
Terg, Rubén, et al.. (1992). Dextran administration avoids hemodynamic changes following paracentesis in cirrhotic patients. Digestive Diseases and Sciences. 37(1). 79–83. 6 indexed citations
18.
Fassio, E, Rubén Terg, Graciela Landeira, et al.. (1992). Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Journal of Hepatology. 14(2-3). 310–316. 63 indexed citations
19.
Terg, Rubén, et al.. (1987). [Spontaneous peritonitis in the patient with cirrhosis, our experience].. PubMed. 17(1). 25–33. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miquel Torres Breakdown of academic impact, for papers by Mariano Cartier Breakdown of academic impact, for papers by Paz Valer Breakdown of academic impact, for papers by K C Tan Breakdown of academic impact, for papers by R.D. Abeles Breakdown of academic impact, for papers by Esther Buzaglo Dantas-Corrêa Breakdown of academic impact, for papers by W. Debernardi‐Venon Breakdown of academic impact, for papers by Giuseppe Cullaro Breakdown of academic impact, for papers by Franco Bissoli Breakdown of academic impact, for papers by L. Martín‐Herrera
Rankless by CCL
2026